Queensland Bauxite Ltd (ASX:QBL) Cover Letter for 3B 19th March 2018
The Board of Queensland Bauxite (ASX:QBL) is pleased to advise that it has cleared the company's outstanding debt by way of share issue.
Companies in the News
Biotech
Queensland Bauxite Ltd (ASX:QBL) Half Year Report
The Directors present their report on Queensland Bauxite Limited, consisting of Queensland Bauxite Limited (ASX:QBL) and the entities it controlled at the end of or during the half-year ended 31 December 2017.
Regeneus Ltd (ASX:RGS) Positive Trial Results of Progenza for Knee Osteoarthritis Published
Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the previously reported positive results from its Phase 1 safety trial of Progenza in patients with knee osteoarthritis have been published in the Journal of Translational Medicine.
Queensland Bauxite Ltd (ASX:QBL) A World First for MCL in Autoimmune Disease Research
The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its subsidiary company Medical Cannabis Limited through its wholly owned subsidiary Medical Cannabis Research Group Pty Ltd, has signed a Research Funding Agreement with the Research & Development Foundation at the Technion Institute, Haifa, Israel.
Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report
Anatara Lifesciences (ASX:ANR) today released its Appendix 4D financial report for the half year ending 31st December 2017.
Regeneus Ltd (ASX:RGS) 2018 Half-Year Results and Business Update
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today released its Half-Year Report for the 6 months to 31 December 2017.
Regeneus Ltd (ASX:RGS) Progenza Granted Advanced Therapy Medicinal Product Designation by European Medicines Agency
Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that Progenza has been granted an Advanced Therapy Medicinal Product classification by the Committee for Advanced Therapies of the European Medicines Agency, following consultation with the European Commission.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
- Beetaloo Energy Australia Limited (ASX:BTL) Commences Carpentaria-5H Hydraulic Stimulation Operations
- Empire Energy Group Ltd (ASX:EEG) Change of Name and ASX Code
- VIDEO: Empire Energy Group Limited (ASX:EEG) Shareholder Support Erupts as Gas Production Draws Closer
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis
Social Media
